LDLR and familial hyperaldosteronism: We next validated our LDL uptake measurements in PBMCs of 2 He-FH patients with highly elevated LDL-c and reduced LDL uptake in EBV lymphoblasts (Cys325Tyr and Ser580Phe mutations in LDLR; Figure S1J).